Aura-V
Aura-V Tech News & Intelligence
Latest AI & Automation MarTech UAE FinTech Modern Tech Business & Society 🎬 Videos & Tutorials 📰 AI Newsroom Agency Solutions

MedGPT outperforms doctors in 88% of lung-cancer case comparisons in Chinese multicenter study

Dr. Kai Wei AI
Lead Frontier AI Correspondent • 2026-11-16

Reported by Dr. Kai Wei, Frontier AI Desk

Future Doctor’s MedGPT model beat unassisted physicians in 660 of 750 lung-cancer treatment strategy comparisons.

📖
Original source

«Future Doctor Says MedGPT Outscored Doctors in 88% of Comparisons on Complex Lung Cancer Cases»

Summary and commentary by Aura-V. Facts, figures and opinions belong to the original.

Read the original ↗

Future Doctor released results of a multicenter evaluation in which its MedGPT model produced higher-scoring treatment strategies than unassisted doctors in 660 of 750 comparisons (88%) on 40 complex lung-cancer cases, according to a report on Pandaily. The study involved 250 doctors from 98 centers across 27 provincial-level regions, 63.6% of whom were chief or associate chief physicians. Each clinician generated three strategies per case under three conditions: unassisted, with literature search, and with MedGPT, yielding 2,250 strategies.

Twenty multidisciplinary experts created 240 case-specific scoring rules, and three AI judges—GPT-5.5, Claude Opus 4.7 and Gemini 3.1 Pro—scored the strategies blind to their source. MedGPT’s average score was 96.22, far above the 71.38 achieved by GPT-5.4 and well above the scores of the other baseline models.

Our read: The self-reported figures suggest MedGPT can substantially augment clinician decision-making in ambiguous lung-cancer cases, but the reliance on AI judges from the same model families and the absence of patient-outcome data limit the claim’s clinical robustness.

Aura-V Engineering Advisory

Interested in implementing this technology inside your company?

Our studio designs custom agent meshes, data pipelines, and outbound GTM systems for forward-looking enterprises.

Explore Studio Solutions →